fda stops semaglutide Live Updates on Semaglutide's Current and Future Uses FDA crackdown on off-brand Ozempic

Understanding the cause helps you manage this uncomfortable symptom effectively

Learn about recent research and possible causes.

Cardiovascular outcome trials (CVOTs) in people living with type 2 diabetes mellitus and obesity have confirmed the cardiovascular benefits of glucagon-like peptide 1 receptor agonists (GLP-1RAs), including reduced cardiovascular mortality, lower ...

Do not reuse a patch

Learn if you can take Zepbound a day late, the 4-day safety rule, and how to stay on track with your weight loss journey.

Ultimate GLP-1 is formulated for women experiencing persistent appetite challenges, frequent cravings, and difficulty managing weight